RDGT Ridgetech Inc. Annual reports only
Retail-Drug Stores and Proprietary Stores · Nasdaq · SEC CIK 1856084 · Fiscal year ends 03/31
Financial factors as of 2026-03-31 (FY2026), by fiscal year; growth vs the previous fiscal year
Growth
TTM revenue YoY10.2%
TTM net income YoY-112.3%
TTM EPS YoY-106.2%
Revenue 3-yr CAGR3.2%
Net income 3-yr CAGR—
Margins
Gross margin3.6%
Operating margin-1.4%
Net margin-0.9%
FCF margin-1.1%
EBITDA margin-1.1%
Returns
ROE-3.6%
ROA-1.9%
ROIC (approx.)-7.4%
Asset turnover1.98x
Leverage & solvency
Liabilities / assets40.9%
Debt / equity0.00x
Current ratio2.31x
Interest coverage-27.82x
Cash quality & payout
Operating cash flow / net income1.11x
Accruals ratio0.2%
Payout ratio—
Capex / revenue0.0%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20262026-03-31 | FY20252025-03-31 | FY20242024-03-31 | FY20232023-03-31 | FY20222022-03-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $132.16M | $119.97M | $123.99M | $120.20M | $164.39M |
| Cost of revenue | $127.41M | $116.13M | $119.12M | $116.60M | $127.87M |
| Gross profit | $4.75M | $3.84M | $4.88M | $3.60M | $36.52M |
| SG&A expense | $3.58M | $3.34M | $3.35M | $5.14M | $8.19M |
| Operating income | -$1.87M | -$1.04M | $596,082 | -$13.16M | -$2.69M |
| Interest expense | $67,069 | -$92,834 | -$197,763 | -$31,582 | $262,218 |
| Pretax income | -$1.35M | -$950,660 | -$827,069 | -$15.44M | -$2.10M |
| Income tax | -$99,098 | $503,524 | -$41,363 | $394,541 | $1.10M |
| Net income | -$1.25M | $10.19M | -$4.23M | -$21.14M | -$3.19M |
| EBITDA | -$1.50M | $101,901 | $1.39M | -$12.44M | -$1.44M |
| EPS (basic) | -17.21 | 275.87 | -439.78 | -41.46 | -18.35 |
| EPS (diluted) | -17.21 | 275.87 | -439.78 | -41.46 | -18.35 |
| Weighted avg. shares (diluted) | 72,668 | 36,954 | 9,628 | 509,828 | 173,966 |
| Banking | |||||
| Net interest income | — | — | $516,637 | $883,908 | $401,921 |
| Deposits | — | — | $32.25M | $31.56M | $35.28M |
| Balance sheet | |||||
| Cash & equivalents | $17.91M | $12.78M | $32.87M | $31.57M | $35.34M |
| Receivables | $32.47M | $27.81M | $6.01M | $14.12M | $16.74M |
| Inventory | $8.26M | $9.76M | $9.08M | $15.31M | $16.02M |
| Current assets | $64.56M | $59.71M | $69.68M | $64.48M | $75.36M |
| PP&E, net | $5,723 | $8,931 | $8,377 | $5.10M | $5.92M |
| Goodwill | $1.46M | $1.46M | — | — | — |
| Intangibles | $3.00M | $3.30M | $1.28M | $3.20M | $3.55M |
| Total assets | $69.03M | $64.48M | $95.06M | $90.97M | $106.38M |
| Current liabilities | $27.89M | $34.36M | $74.36M | $66.54M | $74.45M |
| Short-term debt | — | — | $276,997 | — | — |
| Total liabilities | $28.25M | $34.85M | $80.76M | $74.30M | $83.65M |
| Shareholders' equity | $40.78M | $29.64M | $15.64M | $18.01M | $24.09M |
| Shares outstanding | 887,271 | 39,033 | 1.74M | 1.18M | 3.48M |
| Cash flow statement | |||||
| Operating cash flow | -$1.39M | $1.25M | -$3.16M | -$3.28M | -$5.39M |
| Capital expenditure | $449 | $155,360 | $330,677 | $118,272 | $89,960 |
| Free cash flow | -$1.39M | $1.09M | -$3.49M | -$3.40M | -$5.48M |
| Investing cash flow | -$449 | -$18.14M | -$2.04M | -$316,097 | -$306,138 |
| Financing cash flow | -$29,714 | $1.51M | $8.00M | $2.37M | $4.84M |
| Depreciation & amortization | $363,686 | $1.14M | $790,449 | $718,002 | $1.26M |
| Stock-based compensation | — | — | — | $10.36M | — |
Free plan shows the latest 5 periods; Pro shows all 7 🔒
· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.